EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
Epidermal growth factor receptor (EGFR) and the mutant EGFRvIII are major focal points in current concepts of targeted cancer therapy for glioblastoma multiforme (GBM), the most malignant primary brain tumor. The receptors participate in the key processes of tumor cell invasion and tumor-related ang...
Main Authors: | Stefanie Keller, Mirko H. H. Schmidt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/6/1295 |
Similar Items
-
Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma
by: Emily ePadfield, et al.
Published: (2015-01-01) -
GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma
by: Alphonse, M.P, et al.
Published: (2022) -
GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma
by: Alphonse, M.P, et al.
Published: (2022) -
Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
by: Maxime Fontanilles, et al.
Published: (2020-04-01) -
Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells
by: Xingmei Zhang, et al.
Published: (2018-03-01)